Lonza Group AG (OTCMKTS:LZAGY – Free Report) – Stock analysts at William Blair reduced their FY2025 EPS estimates for shares of Lonza Group in a research report issued on Tuesday, December 3rd. William Blair analyst M. Smock now expects that the company will post earnings of $1.66 per share for the year, down from their previous estimate of $1.78. The consensus estimate for Lonza Group’s current full-year earnings is $1.65 per share.
Several other equities analysts have also issued reports on LZAGY. The Goldman Sachs Group raised shares of Lonza Group to a “strong-buy” rating in a report on Wednesday, October 9th. Redburn Atlantic raised shares of Lonza Group to a “strong-buy” rating in a report on Wednesday, November 27th.
Lonza Group Trading Up 0.7 %
Shares of Lonza Group stock opened at $59.24 on Friday. The firm has a fifty day moving average of $61.42 and a two-hundred day moving average of $60.42. Lonza Group has a 52 week low of $36.71 and a 52 week high of $67.00.
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Recommended Stories
- Five stocks we like better than Lonza Group
- Insider Trades May Not Tell You What You Think
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- What is a support level?
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- The How and Why of Investing in Gold Stocks
- 10 Safe Investments with High Returns
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
